ABT's Structural Heart, Rhythm Management and Neuromodulation businesses are likely to have driven its first-quarter 2025 ...

Abbott Laboratories (NYSE: ABT) stock was in fine health on the second-to-last trading day of the week, thanks to news from Europe. Investors greeted this positively, rewarding the company with a ...

Abbott Laboratories (NYSE:ABT) develops and sells a diverse range of healthcare products including medical devices, diagnostics, nutrition products, and branded generic pharmaceuticals.

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this ...

Under this category, M/S Abbott Asia Investments Limited dominates with 76.26 million shares. Local General Public grabs the ...

Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 ...

Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...

We recently published a list of the 8 Most Profitable Dividend Stocks to Buy Now. In this article, we are going to take a ...

Abbott Laboratories (NYSE:ABT) ranks fifth on our list of the best dividend kings for safe dividend growth. The American ...

The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.

The CE mark is an affirmation by a product's manufacturer that it conforms ... The Motley Fool has positions in and recommends Abbott Laboratories. The Motley Fool has a disclosure policy.